37
Participants
Start Date
February 5, 2015
Primary Completion Date
June 15, 2017
Study Completion Date
June 16, 2017
Ceftolozane/Tazobactam - Multiple Doses
"4-6 doses of ceftolozane/tazobactam every 8 hours as a 60-minute intravenous infusion as follows:~* Participants with CLCR \> 50 mL/min will receive 4-6 doses of 3 g ceftolozane/tazobactam every 8 hours~* Participants with CLCR 30 - 50 mL/min will receive 4-6 doses of 1.5 g ceftolozane/tazobactam every 8 hours~* Participants with CLCR 15 - 29 mL/min will receive 6 doses of 750 mg ceftolozane/tazobactam every 8 hours"
Ceftolozane/Tazobactam - Single Dose
Single dose of ceftolozane/tazobactam, 3 g, as a 60-minute intravenous infusion
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
INDUSTRY